53 Million Prior Auth Decisions: What Medicare Advantage Denials Mean for You

If you're enrolled in a Medicare Advantage plan, there's a good chance you've already encountered prior authorization — or you will. It's the process where your insurer must approve certain treatments, procedures, specialist visits, or medications before you can receive them. And in 2024, Medicare Advantage insurers made nearly 53 million of these determinations, according to data analyzed by KFF (formerly the Kaiser Family Foundation). That number is not a typo. It represents tens of millions of moments where a beneficiary's doctor said 'you need this,' and an insurance company said 'not so fast.'

To understand why this matters, it helps to know what prior authorization actually is and why insurers use it. In theory, prior authorization is a cost-control and care-coordination tool. Insurers argue it prevents unnecessary procedures and ensures patients receive evidence-based treatments. In practice, for many Medicare beneficiaries, it functions as a barrier — a bureaucratic checkpoint that can delay surgeries, hold up cancer treatments, slow access to skilled nursing facilities, or block prescription drugs. When you're 70 years old and your cardiologist says you need a procedure, waiting days or weeks for an insurer to approve it isn't just inconvenient. It can be genuinely dangerous.

The scale of 53 million determinations in a single year is staggering when you put it in context. Medicare Advantage enrolled approximately 33 million beneficiaries in 2024, according to CMS.gov data. That works out to roughly 1.6 prior authorization requests for every single enrollee — on average — over the course of the year. Of course, averages obscure the real picture. Many healthy beneficiaries may go the entire year without triggering a single prior auth requirement. But beneficiaries with serious illnesses, chronic conditions, or complex care needs may face dozens of these hurdles. The people who need care the most are often the ones who face the most authorization barriers.

According to CMS.gov data, the number of Medicare Advantage organizations offering plans has fluctuated in recent years, and plan star ratings — which are supposed to reflect quality — don't always correlate with lower denial rates. In 2024, there were more than 3,800 Medicare Advantage plans available nationally, giving beneficiaries an enormous range of choices but also enormous variation in how aggressively each plan uses prior authorization. A 4-star plan in one county may deny far more requests than a 3-star plan in the next county. Star ratings measure many dimensions of quality, but they don't give you a clean read on how often a specific plan says no to your doctor.

Not every prior authorization determination is a denial — that's an important distinction. Many of those 53 million determinations resulted in approvals. But a meaningful portion did not. CMS data has consistently shown that Medicare Advantage plans deny millions of prior authorization requests each year, and that a significant share of those denials are later overturned on appeal. This is a critical fact for every Medicare Advantage enrollee to understand: if your plan denies a prior authorization request, that is not the end of the road. You have the right to appeal, and the appeals process has real teeth. Internal appeals must be decided within 30 days for standard requests or 72 hours for urgent cases. If the internal appeal fails, you can escalate to an independent review organization — and historically, a substantial percentage of those escalated appeals are decided in the patient's favor.

The federal government has taken notice of the prior authorization problem and has moved to address it with new regulations. CMS finalized a rule in early 2024 that requires Medicare Advantage plans to make standard prior authorization decisions within 7 calendar days (down from 14) and urgent decisions within 72 hours. The rule also requires plans to provide specific clinical reasons when they deny a request — not just a vague reference to 'not medically necessary.' This is a meaningful change because vague denial letters made it extremely difficult for patients and doctors to craft effective appeals. Knowing exactly why a plan said no gives you something concrete to push back against. These rules took effect for plan year 2026, so if you're dealing with a denial today, you should be receiving a specific clinical rationale in writing.

There's also a separate but related issue that has drawn significant scrutiny: the use of artificial intelligence and algorithmic tools in prior authorization decisions. Some Medicare Advantage insurers have used AI-driven screening tools to flag claims for denial at scale, sometimes without adequate individual review of each patient's specific circumstances. Congressional investigations and legal actions have highlighted cases where these tools appeared to generate denials that didn't account for a patient's actual medical history or their physician's clinical judgment. CMS has signaled that prior authorization decisions must be based on individual clinical circumstances, not just algorithmic outputs — but enforcement remains an ongoing challenge.

If you're currently enrolled in a Medicare Advantage plan and want to understand your prior authorization exposure, the most practical step is to review your plan's Evidence of Coverage document, which every plan is required to provide. This document lists which services and medications require prior authorization. You can also call your plan directly and ask a customer service representative to walk you through the prior authorization requirements for any specific treatment your doctor has recommended. Don't wait until after your doctor submits a request to learn that authorization is required — by then, delays are already baked in.

For beneficiaries who are frustrated with prior authorization and considering alternatives, it's worth understanding what traditional Medicare offers by comparison. Original Medicare — Parts A and B — does not use prior authorization for most services. If your doctor says you need a procedure and Medicare covers it, you generally receive it. The trade-off is that Original Medicare has no out-of-pocket maximum, which means a serious illness can expose you to significant costs. Most beneficiaries pair Original Medicare with a Medigap (Medicare Supplement) policy to cap those costs. Medigap Plan G, for example, covers nearly all out-of-pocket costs after the Part B deductible ($257 in 2025), and because it works alongside Original Medicare, there are no prior authorization requirements for covered services. Average Medigap Plan G premiums vary significantly by age, location, and insurer — a 65-year-old might pay $120 to $180 per month in many markets, while a 75-year-old could pay $180 to $280 or more — but the absence of prior authorization is a feature that has real dollar value when you're facing a serious diagnosis.

If you live in one of the states with a birthday rule — California, Idaho, Illinois, Kentucky, Louisiana, Maine, Maryland, Missouri, Nevada, New Jersey, New York, Oklahoma, or Oregon — you have a 30-day window each year around your birthday to switch Medigap plans without medical underwriting. This means even if you have pre-existing conditions, you can move to a different Medigap policy during that window without being denied or charged higher premiums based on your health history. For beneficiaries in these states who are fed up with Medicare Advantage prior authorization, the birthday rule window may be the most practical path to switching to a Medigap-backed Original Medicare setup.

For those who want to stay in Medicare Advantage — and there are legitimate reasons to do so, including dental, vision, and hearing benefits that Original Medicare doesn't cover — the Annual Enrollment Period (AEP) running from October 15 through December 7 each year is your primary opportunity to switch plans. If you're currently in a plan with aggressive prior authorization practices, comparing plans during AEP using Medicare's Plan Finder tool at Medicare.gov can help you identify alternatives. Look specifically at each plan's prior authorization requirements in its Evidence of Coverage, and pay attention to any CMS quality metrics related to appeals and grievances. The Open Enrollment Period (OEP) from January 1 through March 31 also allows Medicare Advantage enrollees to switch to a different Medicare Advantage plan or return to Original Medicare once per year.

Data Snapshot: According to CMS.gov data, Medicare Advantage enrollment reached approximately 33.8 million beneficiaries in 2024, representing more than 54% of all Medicare-eligible individuals. CMS also reported that in contract year 2023 (the most recent year with complete appeals data publicly available), Medicare Advantage plans issued approximately 3.4 million prior authorization denials, and of those that were appealed through the internal appeals process, roughly 82% were overturned — a figure that underscores both how often initial denials are wrong and how important it is for beneficiaries to exercise their appeal rights rather than accepting a denial as final.

The bottom line for Medicare Advantage enrollees is this: prior authorization is a feature of your plan, not a bug — insurers designed it intentionally, and it affects millions of people every year. Knowing your rights, understanding the appeals timeline, and keeping your doctor informed about authorization requirements can meaningfully reduce the impact on your care. And if you're approaching Medicare for the first time or reconsidering your current coverage, the prior authorization question deserves a prominent place in your decision-making — right alongside premiums, networks, and drug formularies.